Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samir Parekh

Showing results (141-150 of 162) with videos related to

Pageof 17
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|August 21, 2018
A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell LymphomaVictor Yazbeck, Danielle Shafer, Edward B Perkins, et al.
Ebiomedicine|November 23, 2023
Cellular mechanisms associated with sub-optimal immune responses to SARS-CoV-2 bivalent booster vaccination in patients with Multiple MyelomaAdolfo Aleman, Morgan van Kesteren, Ariel Kogan Zajdman, et al.
The Journal of Clinical Investigation|February 20, 2024
Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependencySarah Aminov, Orsi Giricz, David T Melnekoff, et al.
Blood|May 8, 2026
Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapiesLucia Y Chen, Adolfo Aleman, Marta Larrayoz, et al.
Blood Cancer Journal|February 25, 2022
Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studiesAdam D Cohen, Samir Parekh, Bianca D Santomasso, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 27, 2020
Summary of the 2019 Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune ProfilingSarah A Holstein, Alan Howard, David Avigan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2025
The novel immunocompetent Eµ-SOX11CCND1 mouse model phenotypically and molecularly resembles human mantle cell lymphomaHedieh Jafari, Fiona Brown-Burke, Betsy Pray, et al.
Blood|June 2, 2023
PRMT5 supports multiple oncogenic pathways in mantle cell lymphomaShelby L Sloan, Fiona Brown, Mackenzie Long, et al.
Blood Advances|November 5, 2025
Long-term Remission After Cilta-Cel in Multiple Myeloma Is Linked to Diverse T Cells and Low Myeloid SuppressionJunia Vieira Dos Santos, David T Melnekoff, Adolfo Aleman, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
An inflammatory cytokine signature helps predict COVID-19 severity and deathDiane Marie Del Valle, Seunghee Kim-Schulze, Huang Hsin-Hui, et al.
Pageof 17

Showing results (141-150 of 162) with videos related to

Sort By:
Pageof 17
Clinical Lymphoma, Myeloma & Leukemia|August 21, 2018
A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell LymphomaVictor Yazbeck, Danielle Shafer, Edward B Perkins, et al.
Ebiomedicine|November 23, 2023
Cellular mechanisms associated with sub-optimal immune responses to SARS-CoV-2 bivalent booster vaccination in patients with Multiple MyelomaAdolfo Aleman, Morgan van Kesteren, Ariel Kogan Zajdman, et al.
The Journal of Clinical Investigation|February 20, 2024
Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependencySarah Aminov, Orsi Giricz, David T Melnekoff, et al.
Blood|May 8, 2026
Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapiesLucia Y Chen, Adolfo Aleman, Marta Larrayoz, et al.
Blood Cancer Journal|February 25, 2022
Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studiesAdam D Cohen, Samir Parekh, Bianca D Santomasso, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 27, 2020
Summary of the 2019 Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune ProfilingSarah A Holstein, Alan Howard, David Avigan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2025
The novel immunocompetent Eµ-SOX11CCND1 mouse model phenotypically and molecularly resembles human mantle cell lymphomaHedieh Jafari, Fiona Brown-Burke, Betsy Pray, et al.
Blood|June 2, 2023
PRMT5 supports multiple oncogenic pathways in mantle cell lymphomaShelby L Sloan, Fiona Brown, Mackenzie Long, et al.
Blood Advances|November 5, 2025
Long-term Remission After Cilta-Cel in Multiple Myeloma Is Linked to Diverse T Cells and Low Myeloid SuppressionJunia Vieira Dos Santos, David T Melnekoff, Adolfo Aleman, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
An inflammatory cytokine signature helps predict COVID-19 severity and deathDiane Marie Del Valle, Seunghee Kim-Schulze, Huang Hsin-Hui, et al.
Pageof 17